Helicobacter pylori clearance in the treatment of non-ulcer dyspepsia.
One hundred and thirty north Nigerian patients with non-ulcer dyspepsia were treated with tripotassium dicitrato bismuthate and amoxycillin, or antacid. Symptoms resolved in 28 (33%) of bismuth and amoxycillin recipients completing the trial compared with 1 (4%) of the antacid recipients. Symptomatic improvement did not relate to clearance of Helicobacter pylori.
Holcombe
C
C
Department of Surgery, University of Maiduguri, Nigeria.
Thom
C
C
Kaluba
J
J
Lucas
S B
SB
D000658:Amoxicillin / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D009549:Nigeria; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011897:Random Allocation
D000863:Antacids; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D000658:Amoxicillin; C002791:bismuth tripotassium dicitrate; D001729:Bismuth